Alere Inc. (ALR)


NYSE - NYSE Real Time Price. Currency in USD
39.55-1.14 (-2.80%)
At close: 4:02 PM EDT
People also watch:
BIOHOLXHAEDXCMCRL
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open40.77
Prev Close40.69
Bid39.56 x 300
Ask39.60 x 400
Day's Range38.80 - 42.12
52wk Range31.47 - 54.79
1y Target EstN/A
Market Cap3.43B
P/E Ratio (ttm)-96.00
Beta-0.29
Volume1,440,401
Avg Vol (3m)1,028,366
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Alere shares fall after it sued Abbott over $5.8 billion deal
    CNBC2 days ago

    Alere shares fall after it sued Abbott over $5.8 billion deal

    Alere fell 3 percent after it sued Abbott to compel it to get all antitrust approvals required to complete its $5.8 billion merger.

  • TheStreet.com2 days ago

    Abbott's Acquisitions in Question as Issues Arise About Alere, St. Jude

    The provider of point-of-care testing has filed a suit in Delaware Chancery Court against Abbott in an effort to complete their pending deal. Meanwhile, St. Jude, gets a griping short-seller.

  • American City Business Journals2 days ago

    Alere sues Abbott to complete $5.8B merger

    Shares of Waltham-based diagnostics firm Alere fell 4 percent on Friday afternoon after the company issued a statement saying it’s suing the company it’s hoping to merge with, Abbott Laboratories. Illinois-based Abbott (ABT) announced an agreement to buy Alere on Feb. 1 for $5.8 billion, but the deal quickly ran into problems.